Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


28.05.2018

1 Biochem Biophys Res Commun
1 Br J Dermatol
1 Clin Cancer Res
1 Clin Exp Metastasis
1 J Am Acad Dermatol
3 Melanoma Res
1 Oncogene


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. LUAN W, Shi Y, Zhou Z, Xia Y, et al
    circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axis.
    Biochem Biophys Res Commun. 2018 May 19. pii: S0006-291X(18)31177.
    PubMed     Text format     Abstract available


    Br J Dermatol

  2. KRAEMER KH, Tamura D, Khan SG
    Pembrolizumab treatment of a patient with xeroderma pigmentosum with disseminated melanoma and multiple nonmelanoma skin cancers.
    Br J Dermatol. 2018;178:1009.
    PubMed     Text format    


    Clin Cancer Res

  3. BEZROOKOVE V, Nosrati M, Miller JR, de Semir D, et al
    Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma.
    Clin Cancer Res. 2018 May 18. pii: 1078-0432.CCR-18-0791.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  4. FARIES MB, Han D, Reintgen M, Kerivan L, et al
    Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials.
    Clin Exp Metastasis. 2018 May 18. pii: 10.1007/s10585-018-9898.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  5. GREENWALD E, Liebman TN, Polsky D, Stein JA, et al
    In response to Stiegel et al, "Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma".
    J Am Acad Dermatol. 2018 May 19. pii: S0190-9622(18)30812.
    PubMed     Text format    


    Melanoma Res

  6. BRUTTING J, Bergmann M, Garzarolli M, Rauschenberg R, et al
    Unmet information needs of patients with melanoma in Germany.
    Melanoma Res. 2018 May 21. doi: 10.1097/CMR.0000000000000464.
    PubMed     Text format     Abstract available

  7. TETERYCZ P, Jagodzinska-Mucha P, Cybulska-Stopa B, Mariuk-Jarema A, et al
    High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors.
    Melanoma Res. 2018 May 18. doi: 10.1097/CMR.0000000000000461.
    PubMed     Text format     Abstract available

  8. FACINA AS, Facina G, Guerreiro da Silva IDC, Correa SAA, et al
    Pregnancy and the apoptotic pathway in experimental melanoma.
    Melanoma Res. 2018 May 17. doi: 10.1097/CMR.0000000000000452.
    PubMed     Text format     Abstract available


    Oncogene

  9. ZHU B, Tang L, Chen S, Yin C, et al
    Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0314.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: